QuantSoar
IndustrialsQuantSoar snapshot generatedΒ·Data source: Yahoo FinanceΒ·Market data may be delayed
IE

IEX Stock Analysis

NYQ Β· Industrials Β· Specialty Industrial Machinery

$231.35

+1.27 (+0.55%)

IEX Interactive Price Chart & Trading Signals

IEX Stock Snapshot β€” Valuation, Risk & Technical Signals

IEX Key Fundamentals, Analyst Targets & Company Profile

Key Financial Ratios

Market Cap

$17.06B

P/E Ratio

33.29

Forward P/E

24.03

PEG Ratio

1.75

P/B Ratio

4.27

EPS

$6.95

Dividend Yield

1.27%

52W Range

$159.27 – $243.80

Beta

0.97

Volume

0.0M

ROE

13.0%

Profit Margin

14.5%

Revenue Growth

6.4%

Gross Margin

44.7%

EV/EBITDA

18.83

Analyst Target

$255.93

The trailing price-to-earnings ratio stands at 33.3x. Forward P/E of 24.0x implies earnings expansion expected. Price-to-book is 4.27x. EV/EBITDA sits at 18.83x. Market capitalization is $17.06B. Revenue is growing at 6.4% on a trailing basis. Earnings are expanding at 10.9%. Profit margins are 14.5%. Return on equity is 13.0%. Beta of 0.97 indicates market-average volatility.

Analyst Consensus

Recommendation

none

Low Target

$215.00

Mean Target

$255.93

High Target

$280.00

Based on 14 analysts

About IEX

IDEX Corporation, together with its subsidiaries, provides applied solutions in the United States, North America, Europe, Asia, and internationally. It operates through three segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT) and Fire & Safety/Diversified Products (FSDP). The HST segment designs, produces, and distributes a range of precision fluidics, positive displacement pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components and sealing solutions, high performance molded and extruded sealing components, and custom mechanical and shaft seals. This segment also offers engineered hygienic mixers and valves, biocompatible medical devices and implantable products, air compressors and blowers, optical components and coatings, ultra-precision diamond tools, and laboratory and commercial equipment, as well as precision photonic solutions, technical ceramics, hermetic sealing products, porous material structures, and flow control solutions. The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, other fluid-handling pump modules, and systems; and provides flow monitoring and other services. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, and rescue tools; lifting bags and other components and systems; engineered stainless steel banding and clamping devices; and precision equipment for dispensing, metering, and mixing colorants and paints. The company was incorporated in 1987 and is headquartered in Northbrook, Illinois.

United States8,700 employeesWebsite β†—

IEX Deep Dive Analysis

Bottom Line

Verdict

Overvalued

Best for

General investor

Watch out for

Premium valuation

Non-zero inputs

4/5

Counts non-zero values for price, P/E, beta, macro risk, and revenue growth; zero may mean unavailable or be a genuine zero.

IDEX Corporation (IEX) trades above our multi-model fair value estimate of $126.75 by approximately 45.2%. Trailing P/E: 33.3x. Profitability signals include profit margin of 14.5% and return on equity of 13.0%. Recent growth metrics show revenue growth of 6.4% and earnings growth of 10.9%. Risk profile: beta of 0.97. Consensus: none.

Valuation, Growth & Risk

Valuation

Overvalued

P/E 33.3x

Price is above what fundamentals suggest.

Growth

Expanding

Rev 6.4%

Revenue is outpacing the market.

Valuation Snapshot

IDEX Corporation (IEX) trades above our multi-model fair value estimate of $126.75 by approximately 45.2%. The trailing price-to-earnings ratio stands at 33.3x. Forward P/E of 24.0x suggests earnings compression ahead. Price-to-sales is 4.8x. Price-to-book is 4.3x. EV/EBITDA sits at 18.8x. Market capitalization is $17.06B.

Why it matters: Paying a premium works only if the company keeps growing faster than expected.

Growth & Profitability

Revenue is growing at 6.4% on a trailing basis. Earnings are expanding at 10.9%. Profit margins are 14.5%. Return on equity is 13.0%. Return on assets is 6.8%.

Why it matters: Growing revenue with healthy margins usually means the business is gaining market share or pricing power.

Risk Profile

Beta of 0.97 indicates market-average volatility. Net debt position is $1.26B.

Why it matters: Lower risk means steadier returns, but often with less upside in bull markets.

Analyst Context

Analyst consensus target of $255.93 implies 10.6% upside. Target range spans $215.00 to $280.00. 14 analysts cover the stock. Consensus recommendation: none.

Why it matters: Analyst targets reflect what professionals expect over 12 months. A wide gap between price and target can mean the market disagrees with the consensus.

Data Methodology & Sources

Market Data (Facts)

  • Price, volume, and market cap: Yahoo Finance (may be delayed)
  • P/E, EPS, revenue, and debt: Yahoo Finance fundamentals
  • Analyst estimates: Yahoo Finance (coverage and update times vary)
  • Insider transactions: Yahoo Finance (reporting may be delayed)

QuantSoar Model (Derived)

  • Fair value: available outputs from seven models; outliers are filtered using MAD (k=3.5), then combined with fixed model weights.
  • Margin of Safety = (Fair Value βˆ’ Displayed Price) / Displayed Price Γ— 100
  • Composite Score: 40% Value + 30% Momentum + 30% Risk
  • Verdict Gauge: Base 50 + Valuation (up to Β±25) + Whale sentiment (up to Β±10) + Insider buying (+5) + Macro risk (up to Β±10) + Technical signal (up to Β±10). Analyst consensus is separate.

Model outputs are estimates based on available data and are not investment advice. Cross-check with primary sources before making investment decisions.

IEX Overvalued

IDEX Corporation (IEX) trades above our multi-model fair value estimate of $126.75 by approximately 45.2%.

Frequently Asked Questions

ValuationIs IEX stock overvalued right now?
Based on our discounted cash flow and relative valuation models, IEX appears to trade above fair value by approximately 45.2%. This suggests the market may be pricing in elevated growth expectations or sentiment premiums.
ValuationWhat is IEX fair value based on current fundamentals?
Our fair value estimate for IEX is $126.75, derived from discounted cash flow, dividend discount, and relative valuation multiples. The estimate assumes a discount rate of 9.0% and terminal growth of 2.5%.
RiskHow risky is IEX compared with other stocks?
Risk profile for IEX: a beta of 0.97 is near market average. Investors should weigh macro exposure against their own risk tolerance.
GrowthIs IEX still growing?
Latest trailing metrics show revenue growth of 6.4% and earnings growth of 10.9%. Profit margins are 14.5%.
AnalystWhat do analysts think about IEX?
Analyst consensus target is $255.93, implying 10.6% upside. The street recommendation is "none".
DividendDoes IEX pay a dividend?
Yes. IEX currently offers a dividend yield of 1.3%.
CatalystWhat could change the investment case for IEX?
Key catalysts include Industrials sector dynamics, interest rate shifts, and company-specific earnings surprises. Monitor macro risk scores and analyst estimate revisions for early signals.

Related Stocks

Phasakorn Traklang (Peach)

About the Author

Phasakorn Traklang (Peach) β€” Founder

Phasakorn Traklang (Peach) is the founder of QuantSoar, bringing expertise in SEO, web development, and technical analytics to build an AI-powered investment platform accessible to retail investors worldwide.

Connect on LinkedIn

Investment Disclaimer: Tax treatment can depend on tax residence, account type, and tax year. This information is general and is not personal tax or investment advice. SEC

Data: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub. AI outputs verified against source data.